Saranac Partners’s Abbott ABT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$443K Buy
11,830
+7,495
+173% +$846K 0.19% 63
2025
Q4
$544K Buy
4,335
+225
+5% +$28.7K 0.21% 51
2025
Q3
$550K Buy
4,110
+205
+5% +$26.9K 0.1% 127
2025
Q2
$531K Buy
3,905
+155
+4% +$20.4K 0.28% 48
2025
Q1
$497K Buy
3,750
+52
+1% +$6.62K 0.28% 47
2024
Q4
$418K Sell
3,698
-550
-13% -$63.6K 0.23% 54
2024
Q3
$484K Buy
4,248
+332
+8% +$36.4K 0.73% 17
2024
Q2
$407K Buy
3,916
+55
+1% +$5.83K 0.24% 50
2024
Q1
$439K Sell
3,861
-10
-0.3% -$1.15K 0.27% 48
2023
Q4
$426K Buy
3,871
+111
+3% +$11.1K 0.28% 55
2023
Q3
$364K Hold
3,760
0.2% 51
2023
Q2
$410K Hold
3,760
0.22% 49
2023
Q1
$381K Buy
+3,760
New +$397K 0.22% 45

Other funds holding ABT

Saranac Partners's ABT Position: Q1 2026 in Review

Saranac Partners increased its Abbott (ABT) stake by 173% in Q1 2026, buying an estimated $846K and bringing the position to 11,830 shares worth $443K. The position accounts for 0.19% of the portfolio, ranked #63.

Saranac Partners first reported a position in ABT in Q1 2023 and has held it in 13 quarters since. The position peaked at $550K in Q3 2025. 3,100 funds tracked by Wall St. Rank hold ABT as of Q1 2026.

  • Saranac Partners held 11,830 shares of Abbott worth $443K as of Q1 2026.
  • Saranac Partners bought 7,495 Abbott shares in Q1 2026, an estimated $846K.
  • Abbott made up 0.19% of Saranac Partners's portfolio in Q1 2026, its #63 holding.
  • Saranac Partners first reported a position in Abbott in Q1 2023 and has held it in 13 quarters since.
  • Saranac Partners's Abbott position peaked at $550K in Q3 2025.
  • 3,100 funds tracked by Wall St. Rank held Abbott as of Q1 2026.

Based on Saranac Partners's 13F filing for Q1 2026, filed 15 May 2026.